06May 2023
Germline Genetic Testing in Unselected Squamous and Non‐Squamous Head and Neck Cancers

Germline Genetic Testing in Unselected Squamous and Non‐Squamous Head and Neck Cancers

The study compared the prevalence of pathogenic germline variants (PGVs) in head and neck cancer patients with guideline-based testing. It also evaluated the uptake of family variant testing. The study found that universal gene panel testing identified a PGV in 10.5% of head and neck cancer patients, and almost all of them would have been missed by current guideline-based testing. Only one patient had a change in care based on the identified PGV. The study suggests that head and neck cancer treatment decisions are not yet widely informed by germline alterations.

  • #ent

Like

Save

Share